|
MGA expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6242562850266E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.6256774532385E-13 |
| Normal-vs-Stage2 |
5.54059997881495E-09 |
| Normal-vs-Stage3 |
5.96411808828634E-13 |
| Normal-vs-Stage4 |
1.71807013060743E-12 |
| Stage1-vs-Stage2 |
3.955800E-01 |
| Stage1-vs-Stage3 |
4.275800E-03 |
| Stage1-vs-Stage4 |
4.604900E-04 |
| Stage2-vs-Stage3 |
2.774400E-01 |
| Stage2-vs-Stage4 |
6.923900E-02 |
| Stage3-vs-Stage4 |
2.954400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.92710292168385E-11 |
| Normal-vs-AfricanAmerican |
3.63850000000276E-05 |
| Normal-vs-Asian |
1.0983000064968E-09 |
| Caucasian-vs-AfricanAmerican |
4.252000E-01 |
| Caucasian-vs-Asian |
9.228000E-01 |
| AfricanAmerican-vs-Asian |
4.249800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.60282939435319E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
2.922200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.24890098263108E-11 |
| Normal-vs-Age(41-60Yrs) |
5.32907051820075E-15 |
| Normal-vs-Age(61-80Yrs) |
3.67483821150927E-13 |
| Normal-vs-Age(81-100Yrs) |
6.32990000000166E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.494300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.455000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.032600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.523430E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.059600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.279200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.156900E-03 |
| Classical-VS-Follicular |
2.325600E-01 |
| Classical-VS-Other |
3.569600E-01 |
| Classical-VS-Normal |
9.56399959228804E-10 |
| Tall-VS-Follicular |
5.719700E-02 |
| Tall-VS-Other |
5.634800E-01 |
| Tall-VS-Normal |
1.3917755836701E-12 |
| Follicular-VS-Other |
6.916800E-01 |
| Follicular-VS-Normal |
7.05659974897799E-11 |
| Other-VS-Normal |
1.084620E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
9.98856553025007E-12 |
| N0-vs-N1 |
2.881200E-01 |
|
|
